AI assistant
DEXCOM INC — Director's Dealing 2013
Mar 13, 2013
30198_dirs_2013-03-13_926c94d1-0bcf-4b36-b53c-2719712af053.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2013-03-11
Reporting Person: GREGG TERRANCE H (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-03-11 | Common Stock | A | 182813 | $0.001 | Acquired | 212813 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 11461 | Indirect |
| Common Stock | 823889 | Indirect |
Footnotes
F1: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/36th shall vest each month beginning one month following the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
F2: Included in this number are 182,813 restricted stock units subject to vesting with respect to 1/36 of the units each month beginning one month following the grant date of March 11, 2013.
F3: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.